MLEC Moolec Science S.A.
Healthcare$7.44+0.00%OpenMarket Cap: $5.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.05
P/S
0.02
EV/EBITDA
-3.65
DCF Value
$3,175.65
FCF Yield
-533.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
34.2%
Operating Margin
-3.1%
Net Margin
-33.4%
ROE
376.8%
ROA
-54.4%
ROIC
-5.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY null | $333.6M | 34.2% | $-10.5M | $-111.5M | $— | — |
| Q2 null | $2.6M | -25.5% | $-2.1M | $-2.4M | $— | — |
| Q1 null | $1.6M | 0.9% | $-2.1M | $-1.9M | $— | — |
| Q4 null | $1.5M | -4.7% | $-2.9M | $-2.5M | $— | — |
| FY null | $5.6M | 8.4% | $-9.0M | $-7.3M | $— | — |
| Q3 null | $2.1M | 4.3% | $-2.0M | $-1.4M | $— | — |
| Q2 null | $252.1K | -3.6% | $-2.0M | $-1.8M | $— | — |
| Q1 null | $1.7M | 12.7% | $-2.3M | $-1.6M | $— | — |
| Q4 null | $905.0K | -15.8% | $-548.4K | $-2.7M | $— | — |
| FY null | $905.0K | -15.8% | $-6.7M | $-51.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-444.7K | $-358.6K | $— | — |
| Q2 2022 | $0.00 | NaN% | $-4.9M | $-48.0M | $-19.20 | — |